Eculizumab treatment of paroxysmal nocturnal hemoglobinuria presenting as Moyamoya syndrome in a 9-year-old male

TING-AN YENMENG-YAO LUMENG-FAI KUOHuang C.-C.Chen J.-S.YUNG-LI YANG2019-11-292019-11-2920121545-5009https://www.scopus.com/inward/record.uri?eid=2-s2.0-84861209452&doi=10.1002%2fpbc.24070&partnerID=40&md5=ded5d382aaa96d0b08ef050e2e845b42https://scholars.lib.ntu.edu.tw/handle/123456789/434491[SDGs]SDG3eculizumab; absence of side effects; anterior cerebral artery; blood analysis; blood cell count; blurred vision; case report; cerebrovascular accident; child; clinical feature; Coombs test; drug safety; flow cytometry; headache; hemolysis; histopathology; human; internal carotid artery; laboratory test; letter; limb weakness; liver function test; magnetic resonance angiography; male; middle cerebral artery; moyamoya disease; neuroimaging; paroxysmal nocturnal hemoglobinuria; priority journal; school child; symptom; treatment duration; treatment outcome; urinalysis; urine composition disorder; Antibodies, Monoclonal, Humanized; Child; Diagnosis, Differential; Hemoglobinuria, Paroxysmal; Humans; Male; Moyamoya DiseaseEculizumab treatment of paroxysmal nocturnal hemoglobinuria presenting as Moyamoya syndrome in a 9-year-old maleletter10.1002/pbc.24070222317492-s2.0-84861209452